MIF Inhibition as a novel treatment for autoimmune myocarditis

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

Thomas Forsthuber

Funded by

Natl Inst of Health

Research Start Date

01/01/2014

Status

Active

Collaborative Project

Basic Research

Drug Discovery

Cardiovascular

Bioscience Research Panel